Balanced translocations that initiate AML, like KMT2Ar—or CBFB-MYH11, RUNX1T1 and PML-RARA—are often mutually exclusive with NPM1 mutations [44,45]. This evidence concerns the gene NPM1 and acute myeloid leukemia.